Chi Ho Lee

Featured in: Favicon

plos.org (+1) Favicon

thelancet.com Favicon

physiciansweekly.com Favicon

diabetesresearchclinicalpractice.com Favicon

gbdmagazine.com Favicon

onlinelibrary.wiley.com Favicon

Articles

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese

Nov 1, 2023 | cell.com | Bariatric Surgery |Guangdong Pharmaceutical |Jacob George |Chi Ho Lee

Highlights•Circulating sCDCP1 is the top-ranked classifier of NASH by Olink proteomics analysis•Hepatic mRNA abundance of CDCP1 is significantly elevated in patients with NASH•The decrease in sCDCP1 mirrors changes in liver enzymes after bariatric surgery•An sCDCP1-based algorithm shows excellent performance for risk stratification of NASHSummaryThe definitive diagnosis of non-alcoholic steatohepatitis (NASH) currently relies on invasive and labor-intensive liver biopsy.
Fracture risks associated with sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong

Feb 11, 2023 | diabetesresearchclinicalpractice.com | LKS Faculty |Tingting Wu |Chi Ho Lee |New Territories

Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaLaboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park, New Territories, Hong Kong SAR, China

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →